200 related articles for article (PubMed ID: 36003916)
1. Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality.
Ng CH; Wong ZY; Chew NWS; Chan KE; Xiao J; Sayed N; Lim WH; Tan DJH; Loke RWK; Tay PWL; Yong JN; Kong G; Huang DQ; Wang JW; Chan M; Dalakoti M; Tamaki N; Noureddin M; Siddiqui MS; Sanyal AJ; Muthiah M
Front Cardiovasc Med; 2022; 9():942753. PubMed ID: 36003916
[TBL] [Abstract][Full Text] [Related]
2. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
Golabi P; Gerber L; Paik JM; Deshpande R; de Avila L; Younossi ZM
JHEP Rep; 2020 Dec; 2(6):100171. PubMed ID: 32964202
[TBL] [Abstract][Full Text] [Related]
3. Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality.
Han H; Yu Q; Qin N; Song B; Meng Y; Feng Z; Li Z; Chen L
Ann Hepatol; 2024; 29(2):101177. PubMed ID: 37924867
[TBL] [Abstract][Full Text] [Related]
4. Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
Heerkens L; van Kleef LA; de Knegt RJ; Voortman T; Geleijnse JM
PLoS One; 2023; 18(9):e0287467. PubMed ID: 37682815
[TBL] [Abstract][Full Text] [Related]
5. The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
Ng CH; Chan KE; Chin YH; Zeng RW; Tsai PC; Lim WH; Tan DJH; Khoo CM; Goh LH; Ling ZJ; Kulkarni A; Mak LL; Huang DQ; Chan M; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M
Clin Mol Hepatol; 2022 Jul; 28(3):565-574. PubMed ID: 35585687
[TBL] [Abstract][Full Text] [Related]
6. Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease.
Wu W; Xiang J; Chen X
Front Endocrinol (Lausanne); 2021; 12():773342. PubMed ID: 34992579
[TBL] [Abstract][Full Text] [Related]
7. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality.
Ng CH; Xiao J; Chew NWS; Chin YH; Chan KE; Quek J; Lim WH; Tan DJH; Loke RWK; Tan C; Tang ASP; Goh XL; Nah B; Syn N; Young DY; Tamaki N; Huang DQ; Siddiqui MS; Noureddin M; Sanyal A; Muthiah M
Front Med (Lausanne); 2022; 9():985803. PubMed ID: 36275825
[TBL] [Abstract][Full Text] [Related]
8. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Clin Endocrinol (Oxf); 2023 Jan; 98(1):49-58. PubMed ID: 35968564
[TBL] [Abstract][Full Text] [Related]
9. The impact of fatigue on mortality of patients with non-alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005-2010 and 2017-2018.
Younossi ZM; Paik JM; Golabi P; Younossi Y; Henry L; Nader F
Liver Int; 2022 Dec; 42(12):2646-2661. PubMed ID: 36161464
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).
Golabi P; Stepanova M; Pham HT; Cable R; Rafiq N; Bush H; Gogoll T; Younossi ZM
BMJ Open Gastroenterol; 2018; 5(1):e000198. PubMed ID: 29607054
[TBL] [Abstract][Full Text] [Related]
11. The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease.
Jung YM; Lee SM; Hong S; Koo JN; Oh IH; Kim BJ; Kim SM; Kim SY; Kim GM; Kyung Joo S; Shin S; Norwitz ER; Park CW; Jun JK; Kim W; Park JS
Liver Int; 2020 Oct; 40(10):2417-2426. PubMed ID: 32558189
[TBL] [Abstract][Full Text] [Related]
12. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
[TBL] [Abstract][Full Text] [Related]
13. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
Mann JP; Carter P; Armstrong MJ; Abdelaziz HK; Uppal H; Patel B; Chandran S; More R; Newsome PN; Potluri R
PLoS One; 2020; 15(10):e0241357. PubMed ID: 33108366
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
16. Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease.
Yu C; Gao J; Ge X; Wang X; Ding Y; Tian T; Xu X; Guo W; Wang Q; Ge Z; Jiang T; Zhang Q; Song C
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145163
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).
George ES; Georgousopoulou EN; Mellor DD; Chrysohoou C; Pitsavos C; Panagiotakos DB
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745097
[TBL] [Abstract][Full Text] [Related]
18. Association of depressive symptoms with all-cause and ischemic heart disease mortality in adults with self-reported hypertension.
Axon RN; Zhao Y; Egede LE
Am J Hypertens; 2010 Jan; 23(1):30-7. PubMed ID: 19893497
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea.
Seo MH; Lee JY; Ryu S; Won YS; Sung KC
Am J Hypertens; 2017 Aug; 30(8):799-807. PubMed ID: 28472229
[TBL] [Abstract][Full Text] [Related]
20. Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD.
Ciardullo S; Bianconi E; Cannistraci R; Parmeggiani P; Marone EM; Perseghin G
J Endocrinol Invest; 2022 Aug; 45(8):1547-1553. PubMed ID: 35364761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
